ArticleJournal for immunotherapy of cancer2022

Serum albumin: a pharmacokinetic marker for optimizing treatment outcome of immune checkpoint blockade.

Ming ZhengPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.